Cone Rod Dystrophy Amelogenesis Imperfecta Overview
Learn About Cone Rod Dystrophy Amelogenesis Imperfecta
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Khanti Rattanapornsompong practices in Bangkok, Thailand. Rattanapornsompong and is rated as an Elite expert by MediFind in the treatment of Cone Rod Dystrophy Amelogenesis Imperfecta. Their top areas of expertise are Cone Rod Dystrophy Amelogenesis Imperfecta, Jalili Syndrome, Cone-Rod Dystrophy, and Maffucci Syndrome.
University Of North Carolina At Chapel Hill
Alessandro Iannaccone is an Ophthalmologist in Chapel Hill, North Carolina. Dr. Iannaccone and is rated as a Distinguished provider by MediFind in the treatment of Cone Rod Dystrophy Amelogenesis Imperfecta. His top areas of expertise are Retinopathy Pigmentary Mental Retardation, Retinitis Pigmentosa, Usher Syndrome Type 2A, and X-Linked Retinitis Pigmentosa (XLRP). Dr. Iannaccone is currently accepting new patients.
Vitreous Retina Macula Consultants Of New York(Downtown)
Dr. Cooney is a practicing vitreoretinal surgeon who was previously an assistant professor of ophthalmology at Johns Hopkins University and later became the director of the Medical Retina Service, the Duke Center for Macular Degeneration, and the medical retina fellowship program from 2001 to 2005. He received a MBA degree from Kenan-Flagler Business School at the University of North Carolina, Chapel Hill.Dr. Cooney serves as a consultant and advisory board member for several pharmaceutical companies. In 1998, Dr. Cooney helped to establish InnoRx, an ophthalmic drug delivery and pharmaceutical company acquired by SurModics and served as a consultant from 2000 to 2002.Dr. Cooney’s clinical practice focuses on the medical and surgical treatment of vitreoretinal diseases, particularly age-related macular degeneration and diabetic retinopathy. He is actively involved in the clinical development of new diagnostic and therapeutic modalities for vitreoretinal disease and the training of residents and fellows.,Dr. Cooney helped establish InnoRx, an ophthalmic drug delivery and pharmaceutical company acquired by SurModics. Dr. Cooney is rated as an Advanced provider by MediFind in the treatment of Cone Rod Dystrophy Amelogenesis Imperfecta. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Artery Occlusion, and Cone-Rod Dystrophy.